Skip to content
Screener

Enliven Therapeutics ELVN Q2 2026 earnings

Reported August 5, 2026 · After market close

EPS-$0.49Miss by $0.10
EPS estimate-$0.39

Next report

Date not yet announced

FAQ

When did Enliven Therapeutics report Q2 2026 earnings?
Enliven Therapeutics (ELVN) reported Q2 2026 earnings on August 5, 2026 after market close.
What were Enliven Therapeutics's Q2 2026 revenue and EPS?
Enliven Therapeutics reported eps of $-0.49 for Q2 2026.
Did Enliven Therapeutics beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.39 by $0.10.
How did Enliven Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 0.0% from $-0.49.
Where can I find Enliven Therapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-335101) and the 10-Q periodic report (0001193125-26-335155) directly on SEC EDGAR. The filing index links above go to sec.gov.